NEW YORK, Dec. 7, 2021 /PRNewswire/ -- The tissue
microarray market share growth by the hospital segment will
be significant for revenue generation. Tissue microarray is used
for disease diagnosis in hospitals. In disease diagnosis
applications, tissue microarrays have a high potential for
analyzing more than thousands of tumor samples on a single slide.
They also allow a high-throughput analysis of proteins and genes
that can provide vital indications in cancer diagnosis. The
global tissue microarray market is expected to grow by
USD 3.14 billion from 2021 to
2206 at a CAGR of 7.75% as per the latest report by
For more insights on the Tissue Microarray
Market - View a FREE sample report in MINUTES
Read the 120-page report with TOC on "Tissue Microarray
Market Analysis Report by End-user (hospitals, clinics, and
diagnostics centers) and Geography (North
Asia, and ROW), and the Segment
Forecasts,2022-2026". Gain competitive intelligence about
market leaders. Track key industry opportunities, trends and
threats. Information on marketing, brand, strategy and market
development, sales, and supply
The tissue microarray market is driven by the growing number
of cancer cases worldwide. However, factors such as the high
cost of instruments and maintenance may impede the market
growth. The holistic analysis of the drivers &
challenges will help in deducing end goals and refining marketing
strategies to gain a competitive edge.
Some of key Tissue Microarray Players:
The tissue microarray market is concentrated and the vendors are
deploying various organic and inorganic growth strategies to
compete in the market.
- Agilent Technologies Inc.
- Arrayit Corp.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- Enzo Biochem Inc.
- Illumina Inc.
- Molecular Devices LLC
- OriGene Technologies Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Get lifetime access to our Technavio Insights.
Subscribe now to our most popular "Lite Plan" billed annually at
USD 3000. View 3 reports monthly and
Download 3 Reports Annually!
Tissue Microarray Market End-user Outlook (Revenue, USD bn,
- Hospitals - size and forecast 2021-2026
- Clinics - size and forecast 2021-2026
- Diagnostics centers - size and forecast 2021-2026
Tissue Microarray Market Geography Outlook (Revenue, USD bn,
- North America - size and
- Europe - size and forecast
- Asia - size and forecast
- ROW - size and forecast 2021-2026
For additional information on Segmentation
-Grab an Exclusive Sample Report
In-vitro Diagnostics Market -The in-vitro diagnostics market
share should rise by USD 35.77 billion from 2021 to
2025 at a CAGR of 7.95%. Download a free sample now!
Molecular Biology Enzymes, Kits, and Reagents Market -The molecular
biology enzymes, kits, and reagents market share should rise by
USD 13.09 billion from 2021 to 2025 at a CAGR of
14.61%. Download a free sample now!
Growth momentum &
Accelerate at a CAGR
Europe, Asia, and ROW
North America at
US, Canada, Germany,
China, UK, Japan, France, India, and Mexico
competitive strategies, consumer engagement scope
Inc., Arrayit Corp., Bio Rad Laboratories Inc., Bio Techne Corp.,
Enzo Biochem Inc., Illumina Inc., Molecular Devices LLC, OriGene
Technologies Inc., PerkinElmer Inc., and Thermo Fisher Scientific
analysis, Market growth inducers and obstacles, Fast-growing and
slow-growing segment analysis, COVID-19 impact and future consumer
dynamics, market condition analysis for the forecast
If our report has not
included the data that you are looking for, you can reach out to
our analysts and get segments customized.
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
View original content to download